antibody          brand name  approval date       type                              target
0            alemtuzumab             campath           2001  humanized                                cd52
1            bevacizumab             avastin           2004  humanized  vascular endothelial growth factor
2    brentuximab vedotin            adcetris           2011   chimeric                                cd30
3              cetuximab             erbitux           2004   chimeric    epidermal growth factor receptor
4  gemtuzumab ozogamicin            mylotarg           2000  humanized                                cd33
5   ibritumomab tiuxetan             zevalin           2002     murine                                cd20
6            panitumumab            vectibix           2006      human    epidermal growth factor receptor
7              rituximab  rituxan , mabthera           1997   chimeric                                cd20
8            trastuzumab           herceptin           1998  humanized                               erbb2

Table as JSON:
{"antibody":{"0":"alemtuzumab","1":"bevacizumab","2":"brentuximab vedotin","3":"cetuximab","4":"gemtuzumab ozogamicin","5":"ibritumomab tiuxetan","6":"panitumumab","7":"rituximab","8":"trastuzumab"},"brand name":{"0":"campath","1":"avastin","2":"adcetris","3":"erbitux","4":"mylotarg","5":"zevalin","6":"vectibix","7":"rituxan , mabthera","8":"herceptin"},"approval date":{"0":2001,"1":2004,"2":2011,"3":2004,"4":2000,"5":2002,"6":2006,"7":1997,"8":1998},"type":{"0":"humanized","1":"humanized","2":"chimeric","3":"chimeric","4":"humanized","5":"murine","6":"human","7":"chimeric","8":"humanized"},"target":{"0":"cd52","1":"vascular endothelial growth factor","2":"cd30","3":"epidermal growth factor receptor","4":"cd33","5":"cd20","6":"epidermal growth factor receptor","7":"cd20","8":"erbb2"}}